Arbutus Biopharma Corp Other Deferred Costs, Net
Arbutus Biopharma Corp (ABUS) had Other Deferred Costs, Net of -$155.87 million as of 2015-03-31, per its 10-Q filed 2015-05-06.
Discontinued › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:OtherDeferredCostsNet · last filed 2015-05-06
- 2013-12-31: Other Deferred Costs, Net 172.95K CAD.
- 2012-12-31: Other Deferred Costs, Net 431.41K CAD; Other Deferred Costs, Net as first filed 429.22K CAD.
- 2011-12-31: Other Deferred Costs, Net 788.11K CAD.
- 2010-12-31: Other Deferred Costs, Net 557.26K CAD.
CAD
| Period end | Other Deferred Costs, Net | Other Deferred Costs, Net as first filed |
|---|---|---|
| 2013-12-31 | 172.95K CAD 10-K · filed 2014-03-28 | |
| 2012-12-31 | 431.41K CAD 10-K · filed 2014-03-28 | 429.22K CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 788.11K CAD 20-F · filed 2013-03-27 | |
| 2010-12-31 | 557.26K CAD 20-F · filed 2012-03-27 |
USD
| Period end | Other Deferred Costs, Net |
|---|---|
| 2015-03-31 | -$155.87M 10-Q · filed 2015-05-06 |
| 2013-12-31 | $173.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |